Marc E. Lippman
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 7
- Cytokine Signaling Pathways and Interactions 2
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Nancy E. Davidson (3 shared papers)Robert B. Dickson (2 shared papers)Robert B. Dickson (5 shared papers)Paul Okunieff (1 shared paper)Kenneth H. Cowan (1 shared paper)Eli Glatstein (1 shared paper)Joan Jacobson (1 shared paper)Seth M. Steinberg (1 shared paper)
- Journals
- Molecular Endocrinology (2 papers)New England Journal of Medicine (2 papers)Investigational New Drugs (1 paper)Cancer Investigation (1 paper)The EMBO Journal (1 paper)
- Partner nations
- United StatesItalyMalaysia
In The Last Decade
Marc E. Lippman
17 papers receiving 2.2k citations
Marc E. Lippman's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 718
- Oncology 894
- Genetics 428
- Immunology and Allergy 87
- Pathology and Forensic Medicine 237
Countries citing papers authored by Marc E. Lippman
This map shows the geographic impact of Marc E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Lippman more than expected).
Fields of papers citing papers by Marc E. Lippman
This network shows the impact of papers produced by Marc E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Lippman. The network helps show where Marc E. Lippman may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc E. Lippman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer Hit paper breakdown → | 1995 | 689 |
| 2 | 1988 | 381 | |
| 3 | 1992 | 243 | |
| 4 | 1987 | 242 | |
| 5 | 1999 | 152 | |
| 6 | 1991 | 122 | |
| 7 | Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. | 2000 | 118 |
| 8 | 1997 | 103 | |
| 9 | Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo. | 1999 | 76 |
| 10 | 1998 | 58 | |
| 11 | 1990 | 43 | |
| 12 | 1999 | 26 | |
| 13 | 1992 | 20 | |
| 14 | 1995 | 12 | |
| 15 | 1987 | 10 | |
| 16 | 1996 | 4 | |
| 17 | 2008 | 2 |
About Marc E. Lippman
Marc E. Lippman is a scholar working on Oncology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 17 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Head and Neck Cancer Studies (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Cancer Research (718 citations), Oncology (894 citations), Genetics (428 citations), Immunology and Allergy (87 citations) and Pathology and Forensic Medicine (237 citations). Marc E. Lippman has collaborated with scholars based in United States, Italy and Malaysia. Frequent co-authors include Nancy E. Davidson, Robert B. Dickson, Robert B. Dickson, Paul Okunieff, Kenneth H. Cowan, Eli Glatstein, Joan Jacobson, Seth M. Steinberg, Teresa D'Angelo and Allen S. Lichter. Their work appears in journals such as Molecular Endocrinology, New England Journal of Medicine, Investigational New Drugs, Cancer Investigation and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.